3D culture for cardiac cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 7, 2016, Pages 1873-1881

  Zuppinger, Christian ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

3D culture; Cardiomyocytes; Cardiotoxicity; Cell culture; Drug screening; Tissue engineering

Indexed keywords

ARTICLE; BIOARTIFICIAL ORGAN; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; ENGINEERED HEART TISSUE; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TUMOR SPHEROID; ANIMAL; CELL COMMUNICATION; CELL CULTURE TECHNIQUE; DRUG DEVELOPMENT; DRUG EFFECTS; HEART DISEASES; MASS COMMUNICATION; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING; TRANSPLANTATION; TRENDS;

CARDIOVASCULAR AGENT;

ANIMALS; CARDIOVASCULAR AGENTS; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DIFFUSION OF INNOVATION; DRUG DISCOVERY; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; PHENOTYPE; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84949674926     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.11.036     Document Type: Article

References (106)

1. Hartung T. Look back in anger-what clinical studies tell us about preclinical work. ALTEX 2013, 30:275-291.
2. Qian L., Srivastava D. Direct cardiac reprogramming: from developmental biology to cardiac regeneration. Circulation Research. 2013, 113:915-921. 10.1161/CIRCRESAHA.112.300625.
3. Georgiadis V., Knight R.A., Jayasinghe S.N., Stephanou A. Cardiac tissue engineering: renewing the arsenal for the battle against heart disease 2014, 6:111-126. 10.1039/c3ib40097b.
4. Eschenhagen T., Mummery C., Knollmann B.C. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc. Res. 2015, 105:424-438. 10.1093/cvr/cvv017.
5. Hirt M.N., Hansen A. T. Eschenhagen. Cardiac tissue engineering: state of the art 2014, 114:354-367. 10.1161/CIRCRESAHA.114.300522.
6. Veerman C.C., Kosmidis G., Mummery C.L., Casini S., Verkerk A.O., Bellin M. Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?. Stem Cells Dev. 2015, 10.1089/scd.2014.0533.
7. Hirt M.N., Boeddinghaus J., Mitchell A., Schaaf S., Börnchen C., Müller C., et al. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J. Mol. Cell. Cardiol. 2014, 10.1016/j.yjmcc.2014.05.009.
8. Kelm J.M., Marchan R. Progress in "body-on-a-chip" research. Arch. Toxicol. 2014, 1-2. 10.1007/s00204-014-1353-0.
9. Frey O., Misun P.M., Fluri D.A., Hengstler J.G., Hierlemann A. Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis. Nat. Commun. 2014, 5:4250. 10.1038/ncomms5250.
10. Gähwiler B.H. Nerve Cells in Culture: The Extraordinary Discovery by Ross Granville Harrison 1999.
11. Burrows M.T. Rhythmical activity of isolated heart muscle cells in vitro. Science 1912, 36:90-92. 10.1126/science.36.916.90.
12. Harary I., Farley B. In vitro studies of single isolated beating heart cells. Science 1960, 131:1674-1675.
13. Halbert S.P., Bruderer R., Lin T.M. In vitro organization of dissociated rat cardiac cells into beating three-dimensional structures. J. Exp. Med. 1971, 133:677-695.
14. Sutherland R.M., Durand R.E. Radiation response of multicell spheroids-an in vitro tumour model. Curr. Top. Radiat. Res. Q. 1976, 11:87-139.
15. Kelm J.M., Ehler E., Nielsen L.K., Schlatter S., Perriard J.-C., Fussenegger M. Design of artificial myocardial microtissues 2004, 10:201-214. 10.1089/107632704322791853.
16. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 2001, 108:407-414. 10.1172/JCI12131.
17. Beauchamp P., Moritz W., Kelm J.M., Ullrich N.D., Agarkova I., Anson B., et al. Development and characterization of a scaffold-free 3D spheroid model of iPSC-derived human cardiomyocytes. Tissue Eng. Part C Methods 2015, 21:852-861. 10.1089/ten.TEC.2014.0376.
18. LEIGHTON J. A sponge matrix method for tissue culture; formation of organized aggregates of cells in vitro. J. Natl. Cancer Inst. 1951, 12:545-561.
19. Vandenburgh H.H., Karlisch P., Farr L. Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell. Dev. Biol. 1988, 24:166-174.
20. Kleinman H.K., McGarvey M.L., Liotta L.A., Robey P.G., Tryggvason K., Martin G.R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982, 21:6188-6193.
21. Vunjak-Novakovic G., Eschenhagen T., Mummery C. Myocardial tissue engineering: in vitro models. Cold Spring Harb Perspect Med. 2014, 4:a014076. (doi:10.1101/cshperspect.a014076).
22. Langer R., Vacanti J.P. Artificial organs. Sci. Am. 1995, 273:130-133.
23. Soonpaa M.H., Koh G.Y., Klug M.G., Field L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994, 264:98-101.
24. Sekine H., Shimizu T., Dobashi I., Matsuura K., Hagiwara N., Takahashi M., et al. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A. 2011, 17:2973-2980. 10.1089/ten.tea.2010.0659.
25. Uusimaa P.A., Hiltunen J.K., Sormunen R.T., Hassinen I.E. Microcarrier culture of neonatal cardiac myocytes in metabolic studies. Cardiovasc. Res. 1988, 22:291-295.
26. Mosadegh B., Xiong G., Dunham S., Min J.K. Current progress in 3D printing for cardiovascular tissue engineering. Biomed. Mater. 2015, 10:034002. 10.1088/1748-6041/10/3/034002.
27. Fennema E., Rivron N., Rouwkema J., van Blitterswijk C., de Boer J. Spheroid culture as a tool for creating 3D complex tissues 2013, 31:108-115. 10.1016/j.tibtech.2012.12.003.
28. Kim J.Y., Fluri D.A., Marchan R., Boonen K., Mohanty S., Singh P., et al. 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis 2015, 205:24-35. 10.1016/j.jbiotec.2015.01.003.
29. Giraud M.-N., Guex A.G., Tevaearai H.T. Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies. Cardiol. Res. Pract. 2012, 2012. (971614-10). 10.1155/2012/971614.
30. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997, 11:683-694.
31. Shevach M., Soffer-Tsur N., Fleischer S., Shapira A., Dvir T. Fabrication of omentum-based matrix for engineering vascularized cardiac tissues. Biofabrication 2014, 6:024101. 10.1088/1758-5082/6/2/024101.
32. Vunjak-Novakovic G., Eschenhagen T., Mummery C. Myocardial tissue engineering: in vitro models. Cold Spring Harb Perspect Med. 2014, 4. (a014076-a014076. doi:10.1101/cshperspect.a014076).
33. Eder A., Vollert I., Hansen A., Eschenhagen T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 2015, 10.1016/j.addr.2015.05.010.
34. Schaaf S., Shibamiya A., Mewe M., Eder A., Stöhr A., Hirt M.N., et al. Human Engineered Heart Tissue As a Versatile Tool in Basic Research and Preclinical Toxicology 2011, 6. 10.1371/journal.pone.0026397.
35. Naito H., Melnychenko I., Didié M., Schneiderbanger K., Schubert P., Rosenkranz S., et al. Optimizing Engineered Heart Tissue for Therapeutic Applications As Surrogate Heart Muscle 2006, 114:I72-I78. 10.1161/CIRCULATIONAHA.105.001560.
36. Tiburcy M., Didié M., Boy O., Christalla P., Döker S., Naito H., et al. Terminal Differentiation, Advanced Organotypic Maturation, and Modeling of Hypertrophic Growth in Engineered Heart Tissue 2011, 109:1105-1114. 10.1161/CIRCRESAHA.111.251843.
37. van Spreeuwel A.C.C., Bax N.A.M., Bastiaens A.J., Foolen J., Loerakker S., Borochin M., et al. The Influence of Matrix (an)Isotropy on Cardiomyocyte Contraction in Engineered Cardiac Microtissues 2014, 10.1039/c3ib40219c.
38. Thavandiran N., Dubois N., Mikryukov A., Massé S., Beca B., Simmons C.A., et al. Design and Formulation of Functional Pluripotent Stem Cell-derived Cardiac Microtissues 2013, 110:E4698-E4707. 10.1073/pnas.1311120110.
39. Katare R.G., Ando M., Kakinuma Y., Sato T. Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro. PLoS ONE 2010, 5. 10.1371/journal.pone.0009275.
40. Crocini C., Arimura T., Reischmann S., Eder A., Braren I., Hansen A., et al. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue. Basic Res. Cardiol. 2013, 108. (349-12). 10.1007/s00395-013-0349-x.
41. Eder A., Hansen A., Uebeler J., Schulze T., Neuber C., Schaaf S., et al. Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue. Basic Res. Cardiol. 2014, 109. (436-15). 10.1007/s00395-014-0436-7.
42. Zimmermann W.-H., Melnychenko I., Wasmeier G., Didié M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006, 12:452-458. 10.1038/nm1394.
43. Bates R.C., Edwards N.S., Yates J.D. Spheroids and cell survival. Crit. Rev. Oncol. Hematol. 2000, 36:61-74.
44. Desroches B.R., Zhang P., Choi B.-R., King M.E., Maldonado A.E., Li W., et al. Functional Scaffold-free 3-D Cardiac Microtissues: A Novel Model for the Investigation of Heart Cells 2012, 302:H2031-H2042. 10.1152/ajpheart.00743.2011.
45. Drewitz M., Helbling M., Fried N., Bieri M., Moritz W., Lichtenberg J., et al. Towards Automated Production and Drug Sensitivity Testing Using Scaffold-free Spherical Tumor Microtissues 2011, 6:1488-1496. 10.1002/biot.201100290.
46. Steinberg M.S., Poole T.J. Strategies for specifying form and pattern: adhesion-guided multicellular assembly. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 1981, 295:451-460.
47. Kelm J.M., Diaz Sanchez-Bustamante C., Ehler E., Hoerstrup S.P., Djonov V., Ittner L., et al. VEGF Profiling and Angiogenesis in Human Microtissues 2005, 118:213-229. 10.1016/j.jbiotec.2005.03.016.
48. Kelm J.M., Djonov V., Hoerstrup S.P., Guenter C.I., Ittner L.M., Greve F., et al. Tissue-transplant Fusion and Vascularization of Myocardial Microtissues and Macrotissues Implanted Into Chicken Embryos and Rats 2006, 12:2541-2553. 10.1089/ten.2006.12.2541.
49. Kelm J.M., Lorber V., Snedeker J.G., Schmidt D., Broggini-Tenzer A., Weisstanner M., et al. A Novel Concept for Scaffold-free Vessel Tissue Engineering: Self-assembly of Microtissue Building Blocks 2010, 148:46-55. 10.1016/j.jbiotec.2010.03.002.
50. Gallet R., Tseliou E., Dawkins J., Middleton R., Valle J., Angert D., et al. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction. Circ. Cardiovasc. Interv. 2015, 8:e002391. 10.1161/CIRCINTERVENTIONS.115.002391.
51. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 2002, 90.
52. Sekine H., Shimizu T., Sakaguchi K., Dobashi I., Wada M., Yamato M., et al. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat. Commun. 2013, 4:1399. 10.1038/ncomms2406.
53. Tsai A.G., Johnson P.C., Intaglietta M. Oxygen gradients in the microcirculation. Physiol. Rev. 2003, 83:933-963. 10.1152/physrev.00034.2002.
54. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature 1980, 288:551-556.
55. Kelm J.M., Diaz Sanchez-Bustamante C., Ehler E., Hoerstrup S.P., Djonov V., Ittner L., et al. VEGF profiling and angiogenesis in human microtissues. J. Biotechnol. 2005, 118:213-229. 10.1016/j.jbiotec.2005.03.016.
56. Bichsel C.A., Hall S.R.R., Schmid R.A., Guenat O.T., Geiser T. Primary human lung pericytes support and stabilize in vitro perfusable microvessels. Tissue Eng. Part A 2015, 21:2166-2176. 10.1089/ten.TEA.2014.0545.
57. Sun X., Altalhi W., Nunes S.S. Vascularization strategies of engineered tissues and their application in cardiac regeneration. Adv. Drug Deliv. Rev. 2015, 10.1016/j.addr.2015.06.001.
58. Hasan A., Paul A., Vrana N.E., Zhao X., Memic A., Hwang Y.-S., et al. Microfluidic techniques for development of 3D vascularized tissue. Biomaterials 2014, 35:7308-7325. 10.1016/j.biomaterials.2014.04.091.
59. Mosadegh B., Xiong G., Dunham S., Min J.K. Current progress in 3D printing for cardiovascular tissue engineering. Biomed. Mater. 2015, 10:034002. 10.1088/1748-6041/10/3/034002.
60. Vukadinovic-Nikolic Z., Andrée B., Dorfman S.E., Pflaum M., Horvath T., Lux M., et al. Generation of bioartificial heart tissue by combining a three-dimensional gel-based cardiac construct with decellularized small intestinal submucosa. Tissue Eng. Part A 2014, 20:799-809. 10.1089/ten.TEA.2013.0184.
61. Robertson M.J., Dries-Devlin J.L., Kren S.M., Burchfield J.S., Taylor D.A. Optimizing recellularization of whole decellularized heart extracellular matrix. PLoS ONE 2014, 9. 10.1371/journal.pone.0090406.
62. Robert J., Weber B., Frese L., Emmert M.Y., Schmidt D., von Eckardstein A., et al. A three-dimensional engineered artery model for in vitro atherosclerosis research. PLoS ONE 2013, 8. 10.1371/journal.pone.0079821.
63. Cerino G., Gaudiello E., Grussenmeyer T., Melly L., Massai D., Banfi A., et al. Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors. Biotechnol. Bioeng. 2015, (n/a-n/a). 10.1002/bit.25688.
64. Tourovskaia A., Fauver M., Kramer G., Simonson S., Neumann T. Tissue-engineered microenvironment systems for modeling human vasculature. Exp. Biol. Med. (Maywood) 2014, 239:1264-1271. 10.1177/1535370214539228.
65. Morgan J.P., Delnero P.F., Zheng Y., Verbridge S.S., Chen J., Craven M., et al. Formation of microvascular networks in vitro. Nat. Protoc. 2013, 8:1820-1836. 10.1038/nprot.2013.110.
66. Hovell C.M., Sei Y.J., Kim Y. Microengineered vascular systems for drug development. J Lab Autom. 2015, 20:251-258. 10.1177/2211068214560767.
67. Thoma C.R., Zimmermann M., Agarkova I., Kelm J.M., Krek W. 3D Cell Culture Systems Modeling Tumor Growth Determinants in Cancer Target Discovery 2014, 10.1016/j.addr.2014.03.001.
68. Desmoulière A., Gabbiani G. Myofibroblast Differentiation During Fibrosis 1995, 3:134-139.
69. Nunes S.S., Miklas J.W., Liu J., Aschar-Sobbi R., Xiao Y., Zhang B., et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10:781-787. 10.1038/nmeth.2524.
70. Kostadinova R., Boess F., Applegate D., Suter L., Weiser T., Singer T., et al. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 2013, 268:1-16. 10.1016/j.taap.2013.01.012.
71. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 2005, 4:489-499. 10.1038/nrd1750.
72. Edling Y., Sivertsson L.K., Butura A., Ingelman-Sundberg M., Ek M. Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol. in Vitro 2009, 23:1387-1395. 10.1016/j.tiv.2009.07.026.
73. Messner S., Agarkova I., Moritz W., Kelm J.M. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch. Toxicol. 2013, 87:209-213. 10.1007/s00204-012-0968-2.
74. Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions 2012, 5:442-452. 10.1161/CIRCEP.110.957647.
75. Barile L., Lionetti V., Cervio E., Matteucci M., Gherghiceanu M., Popescu L.M., et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc. Res. 2014, 103:530-541. 10.1093/cvr/cvu167.
76. Suter-Dick L., Alves P.M., Blaauboer B.J., Bremm K.-D., Brito C., Coecke S., et al. Stem cell-derived systems in toxicology assessment. Stem Cells Dev. 2015, 24:1284-1296. 10.1089/scd.2014.0540.
77. Kola I., Landis J. Can the Pharmaceutical Industry Reduce Attrition Rates? 2004, 3:711-715. 10.1038/nrd1470.
78. Alépée N., Bahinski T., Daneshian M., De Wever B., Fritsche E., Goldberg A., et al. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. Altex 2014, 10.14573/altex1406111.
79. Shah R.R. Can pharmacogenetics help rescue drugs withdrawn from the market?. Pharmacogenomics 2006, 7:889-908. 10.2217/14622416.7.6.889.
80. Roth A., Singer T. The Application of 3D Cell Models to Support Drug Safety Assessment: Opportunities & Challenges 2013, 10.1016/j.addr.2013.12.005.
81. Yeh E.T.H., Tong A.T., Lenihan D.J., Yusuf S.W., Swafford J., Champion C., et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004, 109:3122-3131. 10.1161/01.CIR.0000133187.74800.B9.
82. Zuppinger C., Suter T.M. Cancer Therapy-associated Cardiotoxicity and Signaling in the Myocardium 2010, 56:141-146. 10.1097/FJC.0b013e3181e0f89a.
83. Pickl M., Ries C.H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2009, 28:461-468. 10.1038/onc.2008.394.
84. Garzoni L.R., Adesse D., Soares M.J., Rossi M.I.D., Borojevic R., de N.L.de Meirelles M. Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system. J. Infect. Dis. 2008, 197:906-915. 10.1086/528373.
85. Fink C., Ergün S., Kralisch D., Remmers U., Weil J., Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J. 2000, 14:669-679.
86. Sutherland R.M., Eddy H.A., Bareham B., Reich K., Vanantwerp D. Resistance to Adriamycin in Multicellular Spheroids 1979, 5:1225-1230.
87. Desoize B., Gimonet D., Jardiller J.C. Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res. 1998, 18:4147-4158.
88. Gaedtke L., Thoenes L., Culmsee C., Mayer B., Wagner E. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells. J. Proteome Res. 2007, 6:4111-4118. 10.1021/pr0700596.
89. Hirschhaeuser F., Menne H., Dittfeld C., West J., Mueller-Klieser W., Kunz-Schughart L.A. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 2010, 148:3-15. 10.1016/j.jbiotec.2010.01.012.
90. Tung Y.-C., Hsiao A.Y., Allen S.G., Torisawa Y.-S., Ho M., Takayama S. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 2011, 136:473-478. 10.1039/c0an00609b.
91. Wang H., Tibbitt M.W., Langer S.J., Leinwand L.A., Anseth K.S. Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. PNAS 2013, 110:19336-19341. 10.1073/pnas.1306369110.
92. Eppenberger-Eberhardt M., Aigner S., Donath M.Y., Kurer V., Walther P., Zuppinger C., et al. IGF-I and bFGF Differentially Influence Atrial Natriuretic Factor and Alpha-smooth Muscle Actin Expression in Cultured Atrial Compared to Ventricular Adult Rat Cardiomyocytes 1997, 29:2027-2039. 10.1006/jmcc.1997.0408.
93. Jahnke H.-G., Steel D., Fleischer S., Seidel D., Kurz R., Vinz S., et al. A Novel 3D Label-free Monitoring System of hES-derived Cardiomyocyte Clusters: A Step Forward to In Vitro Cardiotoxicity Testing 2013, 8. 10.1371/journal.pone.0068971.
94. Yang X., Pabon L., Murry C.E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circulation Research. 2014, 114:511-523. 10.1161/CIRCRESAHA.114.300558.
95. Stoppel W.L., Kaplan D.L., Black L.D. Electrical and mechanical stimulation of cardiac cells and tissue constructs. Adv. Drug Deliv. Rev. 2015, 10.1016/j.addr.2015.07.009.
96. Emmert M.Y., Wolint P., Wickboldt N., Gemayel G., Weber B., Brokopp C.E., et al. Human Stem Cell-based Three-dimensional Microtissues for Advanced Cardiac Cell Therapies 2013, 34:6339-6354. 10.1016/j.biomaterials.2013.04.034.
97. Celli J.P., Rizvi I., Blanden A.R., Massodi I., Glidden M.D., Pogue B.W., et al. An Imaging-based Platform for High-content, Quantitative Evaluation of Therapeutic Response in 3D Tumour Models 2014, 4:3751. 10.1038/srep03751.
98. Pampaloni F., Richa R., Ansari N., Stelzer E.H.K. Live spheroid formation recorded with light sheet-based fluorescence microscopy. Methods Mol. Biol. 2015, 1251:43-57. 10.1007/978-1-4939-2080-8_3.
99. Kunysz A.M., Shrier A., Glass L. Bursting behavior during fixed-delay stimulation of spontaneously beating chick heart cell aggregates. Am. J. Physiol. 1997, 273:C331-C346.
100. Zimmermann W.-H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 2000, 68:106-114. 10.1002/(SICI)1097-0290(20000405)68:1<106::AID-BIT13>3.0.CO;2-3.
101. Sanchez-Bustamante C.D., Frey U., Kelm J.M., Hierlemann A., Fussenegger M. Modulation of Cardiomyocyte Electrical Properties Using Regulated Bone Morphogenetic Protein-2 Expression 2008, 14:1969-1988. 10.1089/ten.tea.2007.0302.
102. 2+ transients in engineered heart tissue. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1353-H1363. 10.1152/ajpheart.00705.2013.
103. Hayakawa T., Kunihiro T., Ando T., Kobayashi S., Matsui E., Yada H., et al. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: correlation and complementarity with extracellular electrophysiology. J. Mol. Cell. Cardiol. 2014, 77:178-191. 10.1016/j.yjmcc.2014.09.010.
104. Eschenhagen T., Didié M., Münzel F., Schubert P., Schneiderbanger K., Zimmermann W.-H. 3D Engineered Heart Tissue for Replacement Therapy 2002, 97(Suppl. 1). I146-52.
105. Li T.-S., Cheng K., Lee S.-T., Matsushita S., Davis D., Malliaras K., et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 2010, 28:2088-2098. 10.1002/stem.532.
106. Chiu L.L.Y., Montgomery M., Liang Y., Liu H., Radisic M. Perfusable branching microvessel bed for vascularization of engineered tissues. PNAS 2012, 109:E3414-E3423. 10.1073/pnas.1210580109.